secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lite Strategy, Inc. (LITS)
CIK:        0001262104
Form:       8-K
Filed at:   2023-06-13T23:59:59+00:00
Accession:  0001193125-23-166013
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MEI Pharma Appoints Jay File as EVP Finance, to Become CFO; Brian Drazba to Depart
--------------------------------------------------------------------------------

- Jay File appointed EVP Finance effective June 12, 2023, with base salary $450,000 and target bonus 40%.
- Brian Drazba's tenure as CFO will end no later than September 1, 2023, due to merger with Infinity Pharmaceuticals.
- File received an inducement stock option for 53,302 shares at $7.35 per share, with additional grant contingent on merger closing.
- Board approved amended inducement plan authorizing 92,000 additional shares for equity grants.
- File previously served as CFO of Evofem Biosciences from 2015 to 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1262104/000119312523166013/0001193125-23-166013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1262104/000119312523166013/d516259d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-166013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer